NO20024724L - Profylaktisk og terapeutisk bruk av oltipraz som antifibrotisk og anticirrhotisk middel i leveren og enfarmasöytisk sammensetning som inneholder oltipraz - Google Patents

Profylaktisk og terapeutisk bruk av oltipraz som antifibrotisk og anticirrhotisk middel i leveren og enfarmasöytisk sammensetning som inneholder oltipraz

Info

Publication number
NO20024724L
NO20024724L NO20024724A NO20024724A NO20024724L NO 20024724 L NO20024724 L NO 20024724L NO 20024724 A NO20024724 A NO 20024724A NO 20024724 A NO20024724 A NO 20024724A NO 20024724 L NO20024724 L NO 20024724L
Authority
NO
Norway
Prior art keywords
oltipraz
monopharmaceutical
antifibrotic
prophylactic
liver
Prior art date
Application number
NO20024724A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024724D0 (no
Inventor
Sang-Geon Kim
Keon-Wook Kang
Original Assignee
Sang-Geon Kim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sang-Geon Kim filed Critical Sang-Geon Kim
Publication of NO20024724D0 publication Critical patent/NO20024724D0/no
Publication of NO20024724L publication Critical patent/NO20024724L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20024724A 2000-04-07 2002-10-02 Profylaktisk og terapeutisk bruk av oltipraz som antifibrotisk og anticirrhotisk middel i leveren og enfarmasöytisk sammensetning som inneholder oltipraz NO20024724L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20000018134 2000-04-07
PCT/KR2001/000319 WO2001076604A1 (en) 2000-04-07 2001-03-02 Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz

Publications (2)

Publication Number Publication Date
NO20024724D0 NO20024724D0 (no) 2002-10-02
NO20024724L true NO20024724L (no) 2002-11-29

Family

ID=19662428

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024724A NO20024724L (no) 2000-04-07 2002-10-02 Profylaktisk og terapeutisk bruk av oltipraz som antifibrotisk og anticirrhotisk middel i leveren og enfarmasöytisk sammensetning som inneholder oltipraz

Country Status (16)

Country Link
US (1) US20030191137A1 (ru)
EP (1) EP1292309A4 (ru)
JP (1) JP2003530353A (ru)
KR (1) KR100404303B1 (ru)
CN (1) CN1192775C (ru)
AU (1) AU780161B2 (ru)
BR (1) BR0109747A (ru)
CA (1) CA2404915A1 (ru)
HU (1) HUP0300221A3 (ru)
MX (1) MXPA02009695A (ru)
NO (1) NO20024724L (ru)
NZ (1) NZ521710A (ru)
PL (1) PL362965A1 (ru)
RU (1) RU2258509C2 (ru)
WO (1) WO2001076604A1 (ru)
ZA (1) ZA200207867B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078045B2 (en) 2000-03-02 2006-07-18 Sang-Geon Kim Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
KR20030067935A (ko) * 2002-02-09 2003-08-19 김상건 올티프라즈를 포함하는 간경화(간경변증) 치료를 위한 간 조직 재생용 제약 조성물
KR100491318B1 (ko) * 2002-11-26 2005-05-24 씨제이 주식회사 올티프라즈(Ｏｌｔｉｐｒａｚ) 제조방법
KR100476069B1 (ko) * 2003-02-12 2005-03-10 주식회사 태평양 １，２－디티올티온 유도체를 함유하는 발모촉진용 또는탈모방지용 조성물
KR100629771B1 (ko) * 2004-01-27 2006-09-28 씨제이 주식회사 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법
KR100604261B1 (ko) * 2004-10-11 2006-07-28 재단법인서울대학교산학협력재단 신규4,5,6,7-테트라히드로-[1,2]디티올로[4,3-ｃ]피리딘-3-티온계 화합물
KR100590818B1 (ko) 2004-10-11 2006-06-19 재단법인서울대학교산학협력재단 소분자 유기화합물의 직접적 ｐ90 리보솜 Ｓ6 키나제 1(ＲＳＫ1)의 활성증진에 의한 당뇨병, 비만 및대사증후군의 예방 및 치료용도
KR20060031956A (ko) * 2004-10-11 2006-04-14 재단법인서울대학교산학협력재단 ｐ90 리보솜 Ｓ6 키나제 1 (ＲＳＫ1)의 직접적인 키나제활성증진을 통한 간섬유화와 간경변증 예방 및 치료용약학조성물
US8076311B2 (en) * 2006-05-11 2011-12-13 Prendergast Patrick T Compositions and methods for modulating the immune system
KR101057485B1 (ko) * 2008-08-04 2011-08-17 서울대학교산학협력단 1,2-디티올티온 유도체를 함유하는 엘엑스알-알파 과다발현으로 인한 질병의 예방 및 치료용 약학 조성물
JP6403217B2 (ja) * 2013-07-30 2018-10-10 京都府公立大学法人 角膜内皮ｅｃｍ治療薬
EP3804760A1 (en) 2013-10-31 2021-04-14 Kyoto Prefectural Public University Corporation Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium
US20160376259A1 (en) 2015-06-25 2016-12-29 St Ip Holding Ag Methods for Preparing Oltipraz
US11364239B2 (en) 2020-04-29 2022-06-21 Cfd Research Corporation Compositions and methods for mitigating aflatoxin B1-induced liver injury
CN112546216B (zh) * 2020-11-20 2022-10-28 西湖大学 小分子化合物奥替普拉在制备增强体液免疫应答的药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794873A (fr) * 1972-02-02 1973-08-01 Rhone Poulenc Sa Nouvelles sulfones a enchainement dimethyl-1,6 hexadien-1,5 ylene
DE2505869C3 (de) * 1975-02-12 1978-05-18 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von symmetrischen Carotinoiden
JPS54160740A (en) * 1978-06-09 1979-12-19 Takeda Chem Ind Ltd Anti-fibrotic agent
US4883887A (en) * 1987-07-09 1989-11-28 Hoffmann-La Roche Inc. Sulfone polyene intermediates
US6517824B1 (en) * 1990-05-14 2003-02-11 University Of Medicine & Denistry Of New Jersey Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor
US5637315A (en) * 1993-01-04 1997-06-10 Thomas Jefferson University Treatment of disease states induced by oxidative stress
KR0138005B1 (ko) * 1993-10-21 1998-05-15 김낙두 신규의 화학적 보호제(chemopreventive agent)및 그의 제조방법
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
EP0827742A1 (en) * 1996-09-04 1998-03-11 Vrije Universiteit Brussel Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
CA2650204A1 (en) * 1996-12-31 1998-07-09 Harry B. Demopoulos Pharmaceutical preparations of glutathione and methods of administration thereof
US6294350B1 (en) * 1997-06-05 2001-09-25 Dalhousie University Methods for treating fibroproliferative diseases
US6046199A (en) * 1998-01-14 2000-04-04 Cell Pathways, Inc. Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives
KR100261139B1 (ko) * 1998-01-16 2000-08-01 황준수 신규한 알릴티오피리다진 유도체 및 그의 제조방법
US6242478B1 (en) * 1999-12-10 2001-06-05 Wake Forest University Five member ring sulfenate esters and thiosulfinate esters

Also Published As

Publication number Publication date
NZ521710A (en) 2004-06-25
HUP0300221A2 (hu) 2003-07-28
AU780161B2 (en) 2005-03-03
US20030191137A1 (en) 2003-10-09
ZA200207867B (en) 2003-08-01
HUP0300221A3 (en) 2003-09-29
RU2258509C2 (ru) 2005-08-20
MXPA02009695A (es) 2003-03-27
NO20024724D0 (no) 2002-10-02
BR0109747A (pt) 2003-02-04
EP1292309A4 (en) 2004-08-11
WO2001076604A1 (en) 2001-10-18
JP2003530353A (ja) 2003-10-14
EP1292309A1 (en) 2003-03-19
CN1192775C (zh) 2005-03-16
PL362965A1 (en) 2004-11-02
CN1420772A (zh) 2003-05-28
KR20010091012A (ko) 2001-10-22
AU3776701A (en) 2001-10-23
KR100404303B1 (ko) 2003-11-03
CA2404915A1 (en) 2001-10-18
RU2002129873A (ru) 2004-03-27

Similar Documents

Publication Publication Date Title
HUP0301452A3 (en) Pharmaceutical composition containing photochemotherapeutic agent and mucoadhesive agent and its use
EE200400059A (et) Diarüültsükloalküülderivaadid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
NO20024724D0 (no) Profylaktisk og terapeutisk bruk av oltipraz som antifibrotisk og anticirrhotisk middel i leveren og enfarmasöytisk sammensetning som inneholder oltipraz
EE05149B1 (et) Biarlkarboksamiidid, meetod nende valmistamiseks, neid sisaldav ravimkoostis ning nende kasutamine ravis
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
IL163278A (en) Formulations including glp-1 compounds and their use in drug preparation
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
HUP0400202A3 (en) Imidazolidindion derivatives having metalloproteinase inhibitor effect, their use and pharmaceutical compositions containing them
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
IL151952A0 (en) Aminopyridine derivatives and pharmaceutical compositions containing the same
AU6118001A (en) Combination therapeutic compositions and methods of use
NO20015782D0 (no) Kostblanding eller farmasöytisk sammensetning til anvendelse for forebyggelse eller behandling av hyperoksaluri
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
HUP0400052A3 (en) Carboxamide-substituted phenylurea derivatives and pharmaceutical compositions containing them and their use
IL158076A0 (en) Benzamidine derivatives and pharmaceutical compositions containing the same
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
AU2002335046A1 (en) The use of proton sequestering agents in drug formulations
WO2004000293A3 (fr) Utilisation de la taurine ou de derives pour le traitement de l'alopecie
NO20031622D0 (no) Medisinske blandinger som raskt desintegrerer i munnhulen og fremgangsmåtefor fremstilling av samme
IL152846A0 (en) Pyridazinone derivatives and pharmaceutical compositions containing the same
AU2002361060A1 (en) Use of apple core extracts in cosmetic or pharmaceutical compositions
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
AU2002346594A1 (en) Use of hiv-1 protease inhibitors and their derivatives in the treatment of inflammation
HUP0302255A3 (en) Sulfonamide derivatives, pharmaceutical compositions containing them and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application